Selected research
Market Outlook & Growth Opportunities
Global Medical Device Validation Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Device Validation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Device Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Device Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Device Validation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Device Validation Service market include SGS, QuEST, Global Services, Intertek, Element Materials Technology, TÜV SÜD, NAMSA, Eurofins Scientific and Charles River, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical Device Validation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Device Validation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Device Validation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Validation Service market.
Medical Device Validation Service Segment by Company
SGS
QuEST
Global Services
Intertek
Element Materials Technology
TÜV SÜD
NAMSA
Eurofins Scientific
Charles River
Sterling Medical Devices
Pacific Biolabs
Toxikon
Steris Laboratories
Europlaz
HIGHPOWER Validation Testing & Lab Services
Tata Elxsi
Onyx Healthcare
QAEC
Zener Engineering Services
Lucideon
Applus+ Laboratories
Patient Guard
Medical Engineering Technologies
Tentamus
Test Labs
Medical Device Validation Service Segment by Type
Process Validation
Equipment Validation
Software Validation
Design Validation
Compliance Validation
Others
Medical Device Validation Service Segment by Application
Medical Device Manufacturing
Pharmaceutical and Biotech Equipment
Healthcare IT and Software Devices
Clinical and Laboratory Equipment
Others
Medical Device Validation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical Device Validation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical Device Validation Service key companies, revenue, market share, and recent developments.
3. To split the Medical Device Validation Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical Device Validation Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Device Validation Service significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Device Validation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Validation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Validation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Validation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Validation Service industry.
Chapter 3: Detailed analysis of Medical Device Validation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical Device Validation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical Device Validation Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Medical Device Validation Service Industry Trends
Table 2. Medical Device Validation Service Industry Drivers
Table 3. Medical Device Validation Service Industry Opportunities and Challenges
Table 4. Medical Device Validation Service Industry Restraints
Table 5. Global Medical Device Validation Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Medical Device Validation Service Revenue Share by Company (2021-2026)
Table 7. Global Medical Device Validation Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Medical Device Validation Service Key Company Manufacturing Base & Headquarters
Table 9. Global Medical Device Validation Service Company, Product Type & Application
Table 10. Global Medical Device Validation Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Medical Device Validation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Process Validation
Table 15. Significant Companies of Equipment Validation
Table 16. Significant Companies of Software Validation
Table 17. Significant Companies of Design Validation
Table 18. Significant Companies of Compliance Validation
Table 19. Significant Companies of Others
Table 20. Global Medical Device Validation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 21. Global Medical Device Validation Service Sales Value by Type (2021-2026) & (US$ Million)
Table 22. Global Medical Device Validation Service Sales Value by Type (2027-2032) & (US$ Million)
Table 23. Global Medical Device Validation Service Sales Value Share by Type (2021-2026)
Table 24. Global Medical Device Validation Service Sales Value Share by Type (2027-2032)
Table 25. Significant Companies of Medical Device Manufacturing
Table 26. Significant Companies of Pharmaceutical and Biotech Equipment
Table 27. Significant Companies of Healthcare IT and Software Devices
Table 28. Significant Companies of Clinical and Laboratory Equipment
Table 29. Significant Companies of Others
Table 30. Global Medical Device Validation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Medical Device Validation Service Sales Value by Application (2021-2026) & (US$ Million)
Table 32. Global Medical Device Validation Service Sales Value by Application (2027-2032) & (US$ Million)
Table 33. Global Medical Device Validation Service Sales Value Share by Application (2021-2026)
Table 34. Global Medical Device Validation Service Sales Value Share by Application (2027-2032)
Table 35. Global Medical Device Validation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Medical Device Validation Service Sales Value by Region (2021-2026) & (US$ Million)
Table 37. Global Medical Device Validation Service Sales Value Share by Region (2021-2026)
Table 38. Global Medical Device Validation Service Sales Value by Region (2027-2032) & (US$ Million)
Table 39. Global Medical Device Validation Service Sales Value Share by Region (2027-2032)
Table 40. Global Medical Device Validation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 41. Global Medical Device Validation Service Sales Value by Country (2021-2026) & (US$ Million)
Table 42. Global Medical Device Validation Service Sales Value Market Share by Country (2021-2026)
Table 43. Global Medical Device Validation Service Sales Value by Country (2027-2032) & (US$ Million)
Table 44. Global Medical Device Validation Service Sales Value Market Share by Country (2027-2032)
Table 45. SGS Company Information
Table 46. SGS Business Overview
Table 47. SGS Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. SGS Medical Device Validation Service Product Portfolio
Table 49. SGS Recent Development
Table 50. QuEST Company Information
Table 51. QuEST Business Overview
Table 52. QuEST Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. QuEST Medical Device Validation Service Product Portfolio
Table 54. QuEST Recent Development
Table 55. Global Services Company Information
Table 56. Global Services Business Overview
Table 57. Global Services Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. Global Services Medical Device Validation Service Product Portfolio
Table 59. Global Services Recent Development
Table 60. Intertek Company Information
Table 61. Intertek Business Overview
Table 62. Intertek Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Intertek Medical Device Validation Service Product Portfolio
Table 64. Intertek Recent Development
Table 65. Element Materials Technology Company Information
Table 66. Element Materials Technology Business Overview
Table 67. Element Materials Technology Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Element Materials Technology Medical Device Validation Service Product Portfolio
Table 69. Element Materials Technology Recent Development
Table 70. TÜV SÜD Company Information
Table 71. TÜV SÜD Business Overview
Table 72. TÜV SÜD Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. TÜV SÜD Medical Device Validation Service Product Portfolio
Table 74. TÜV SÜD Recent Development
Table 75. NAMSA Company Information
Table 76. NAMSA Business Overview
Table 77. NAMSA Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. NAMSA Medical Device Validation Service Product Portfolio
Table 79. NAMSA Recent Development
Table 80. Eurofins Scientific Company Information
Table 81. Eurofins Scientific Business Overview
Table 82. Eurofins Scientific Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Eurofins Scientific Medical Device Validation Service Product Portfolio
Table 84. Eurofins Scientific Recent Development
Table 85. Charles River Company Information
Table 86. Charles River Business Overview
Table 87. Charles River Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Charles River Medical Device Validation Service Product Portfolio
Table 89. Charles River Recent Development
Table 90. Sterling Medical Devices Company Information
Table 91. Sterling Medical Devices Business Overview
Table 92. Sterling Medical Devices Medical Device Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Sterling Medical Devices Medical Device Validation Service Product Portfolio
Table 94. Sterling Medical Devices Recent Development
Table 95. Pacific Biolabs Company Information
Table 96. Pacific Biolabs Business Overview
Table 97. Pacific Biolabs Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. Pacific Biolabs Medical Device Validation Service Product Portfolio
Table 99. Pacific Biolabs Recent Development
Table 100. Toxikon Company Information
Table 101. Toxikon Business Overview
Table 102. Toxikon Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. Toxikon Medical Device Validation Service Product Portfolio
Table 104. Toxikon Recent Development
Table 105. Steris Laboratories Company Information
Table 106. Steris Laboratories Business Overview
Table 107. Steris Laboratories Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 108. Steris Laboratories Medical Device Validation Service Product Portfolio
Table 109. Steris Laboratories Recent Development
Table 110. Europlaz Company Information
Table 111. Europlaz Business Overview
Table 112. Europlaz Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 113. Europlaz Medical Device Validation Service Product Portfolio
Table 114. Europlaz Recent Development
Table 115. HIGHPOWER Validation Testing & Lab Services Company Information
Table 116. HIGHPOWER Validation Testing & Lab Services Business Overview
Table 117. HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 118. HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Product Portfolio
Table 119. HIGHPOWER Validation Testing & Lab Services Recent Development
Table 120. Tata Elxsi Company Information
Table 121. Tata Elxsi Business Overview
Table 122. Tata Elxsi Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 123. Tata Elxsi Medical Device Validation Service Product Portfolio
Table 124. Tata Elxsi Recent Development
Table 125. Onyx Healthcare Company Information
Table 126. Onyx Healthcare Business Overview
Table 127. Onyx Healthcare Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 128. Onyx Healthcare Medical Device Validation Service Product Portfolio
Table 129. Onyx Healthcare Recent Development
Table 130. QAEC Company Information
Table 131. QAEC Business Overview
Table 132. QAEC Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 133. QAEC Medical Device Validation Service Product Portfolio
Table 134. QAEC Recent Development
Table 135. Zener Engineering Services Company Information
Table 136. Zener Engineering Services Business Overview
Table 137. Zener Engineering Services Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 138. Zener Engineering Services Medical Device Validation Service Product Portfolio
Table 139. Zener Engineering Services Recent Development
Table 140. Lucideon Company Information
Table 141. Lucideon Business Overview
Table 142. Lucideon Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 143. Lucideon Medical Device Validation Service Product Portfolio
Table 144. Lucideon Recent Development
Table 145. Applus+ Laboratories Company Information
Table 146. Applus+ Laboratories Business Overview
Table 147. Applus+ Laboratories Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 148. Applus+ Laboratories Medical Device Validation Service Product Portfolio
Table 149. Applus+ Laboratories Recent Development
Table 150. Patient Guard Company Information
Table 151. Patient Guard Business Overview
Table 152. Patient Guard Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 153. Patient Guard Medical Device Validation Service Product Portfolio
Table 154. Patient Guard Recent Development
Table 155. Medical Engineering Technologies Company Information
Table 156. Medical Engineering Technologies Business Overview
Table 157. Medical Engineering Technologies Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 158. Medical Engineering Technologies Medical Device Validation Service Product Portfolio
Table 159. Medical Engineering Technologies Recent Development
Table 160. Tentamus Company Information
Table 161. Tentamus Business Overview
Table 162. Tentamus Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 163. Tentamus Medical Device Validation Service Product Portfolio
Table 164. Tentamus Recent Development
Table 165. Test Labs Company Information
Table 166. Test Labs Business Overview
Table 167. Test Labs Medical Device Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 168. Test Labs Medical Device Validation Service Product Portfolio
Table 169. Test Labs Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Authors List of This Report
Table 172. Secondary Sources
Table 173. Primary Sources
List of Figures
Figure 1. Medical Device Validation Service Product Image
Figure 2. Global Medical Device Validation Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Medical Device Validation Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Medical Device Validation Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Process Validation Image
Figure 8. Equipment Validation Image
Figure 9. Software Validation Image
Figure 10. Design Validation Image
Figure 11. Compliance Validation Image
Figure 12. Others Image
Figure 13. Global Medical Device Validation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Medical Device Validation Service Sales Value Share 2021 VS 2025 VS 2032
Figure 15. Global Medical Device Validation Service Sales Value Share by Type (2021-2032)
Figure 16. Medical Device Manufacturing Image
Figure 17. Pharmaceutical and Biotech Equipment Image
Figure 18. Healthcare IT and Software Devices Image
Figure 19. Clinical and Laboratory Equipment Image
Figure 20. Others Image
Figure 21. Global Medical Device Validation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Medical Device Validation Service Sales Value Share 2021 VS 2025 VS 2032
Figure 23. Global Medical Device Validation Service Sales Value Share by Application (2021-2032)
Figure 24. Global Medical Device Validation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 25. Global Medical Device Validation Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 26. North America Medical Device Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 27. North America Medical Device Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Europe Medical Device Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 29. Europe Medical Device Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Asia-Pacific Medical Device Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 31. Asia-Pacific Medical Device Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 32. South America Medical Device Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 33. South America Medical Device Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Middle East & Africa Medical Device Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 35. Middle East & Africa Medical Device Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 36. USA Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. USA Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. USA Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Canada Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Canada Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Canada Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Mexico Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Mexico Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Mexico Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. Germany Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. Germany Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. Germany Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. France Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. France Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. France Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. U.K. Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. U.K. Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. U.K. Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Italy Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Italy Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Italy Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Spain Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Spain Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Spain Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Russia Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Russia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Russia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Netherlands Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Netherlands Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Netherlands Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Nordic Countries Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Nordic Countries Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Nordic Countries Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. China Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. China Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. China Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. Japan Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. Japan Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. Japan Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. South Korea Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. South Korea Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. South Korea Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. India Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. India Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. India Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Australia Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Australia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Australia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Southeast Asia Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Southeast Asia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Southeast Asia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Brazil Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Brazil Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Brazil Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Argentina Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Argentina Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Argentina Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Chile Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Chile Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Chile Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Colombia Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Colombia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Colombia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Peru Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Peru Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Peru Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Saudi Arabia Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Saudi Arabia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Saudi Arabia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Israel Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Israel Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Israel Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. UAE Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. UAE Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. UAE Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Turkey Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Turkey Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Turkey Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Iran Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Iran Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Iran Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Egypt Medical Device Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 118. Egypt Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 119. Egypt Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 120. Years Considered
Figure 121. Research Process
Figure 122. Key Executives Interviewed
Scope & coverage.
Types
- Process Validation
- Equipment Validation
- Software Validation
- Design Validation
- Compliance Validation
- Others
Applications
- Medical Device Manufacturing
- Pharmaceutical and Biotech Equipment
- Healthcare IT and Software Devices
- Clinical and Laboratory Equipment
- Others
Companies covered
- SGS
- QuEST
- Global Services
- Intertek
- Element Materials Technology
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- Charles River
- Sterling Medical Devices
- Pacific Biolabs
- Toxikon
- Steris Laboratories
- Europlaz
- HIGHPOWER Validation Testing & Lab Services
- Tata Elxsi
- Onyx Healthcare
- QAEC
- Zener Engineering Services
- Lucideon
- Applus+ Laboratories
- Patient Guard
- Medical Engineering Technologies
- Tentamus
- Test Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Device Validation Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Device Validation Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Validation Service Market Dynamics
- 2.1 Medical Device Validation Service Industry Trends
- 2.2 Medical Device Validation Service Industry Drivers
- 2.3 Medical Device Validation Service Industry Opportunities and Challenges
- 2.4 Medical Device Validation Service Industry Restraints
3 Medical Device Validation Service Market by Company
- 3.1 Global Medical Device Validation Service Company Revenue Ranking in 2025
- 3.2 Global Medical Device Validation Service Revenue by Company (2021-2026)
- 3.3 Global Medical Device Validation Service Company Ranking (2024-2026)
- 3.4 Global Medical Device Validation Service Company Manufacturing Base and Headquarters
- 3.5 Global Medical Device Validation Service Company Product Type and Application
- 3.6 Global Medical Device Validation Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical Device Validation Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical Device Validation Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical Device Validation Service Market by Type
- 4.1 Medical Device Validation Service Type Introduction
- 4.1.1 Process Validation
- 4.1.2 Equipment Validation
- 4.1.3 Software Validation
- 4.1.4 Design Validation
- 4.1.5 Compliance Validation
- 4.1.6 Others
- 4.2 Global Medical Device Validation Service Sales Value by Type
- 4.2.1 Global Medical Device Validation Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Device Validation Service Sales Value by Type (2021-2032)
- 4.2.3 Global Medical Device Validation Service Sales Value Share by Type (2021-2032)
5 Medical Device Validation Service Market by Application
- 5.1 Medical Device Validation Service Application Introduction
- 5.1.1 Medical Device Manufacturing
- 5.1.2 Pharmaceutical and Biotech Equipment
- 5.1.3 Healthcare IT and Software Devices
- 5.1.4 Clinical and Laboratory Equipment
- 5.1.5 Others
- 5.2 Global Medical Device Validation Service Sales Value by Application
- 5.2.1 Global Medical Device Validation Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Device Validation Service Sales Value by Application (2021-2032)
- 5.2.3 Global Medical Device Validation Service Sales Value Share by Application (2021-2032)
6 Medical Device Validation Service Regional Value Analysis
- 6.1 Global Medical Device Validation Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Device Validation Service Sales Value by Region (2021-2032)
- 6.2.1 Global Medical Device Validation Service Sales Value by Region: 2021-2026
- 6.2.2 Global Medical Device Validation Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Device Validation Service Sales Value (2021-2032)
- 6.3.2 North America Medical Device Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical Device Validation Service Sales Value (2021-2032)
- 6.4.2 Europe Medical Device Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical Device Validation Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical Device Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical Device Validation Service Sales Value (2021-2032)
- 6.6.2 South America Medical Device Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical Device Validation Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical Device Validation Service Sales Value Share by Country, 2025 VS 2032
7 Medical Device Validation Service Country-level Value Analysis
- 7.1 Global Medical Device Validation Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Device Validation Service Sales Value by Country (2021-2032)
- 7.2.1 Global Medical Device Validation Service Sales Value by Country (2021-2026)
- 7.2.2 Global Medical Device Validation Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical Device Validation Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical Device Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical Device Validation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Medical Device Validation Service Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 QuEST
- 8.2.1 QuEST Company Information
- 8.2.2 QuEST Business Overview
- 8.2.3 QuEST Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.2.4 QuEST Medical Device Validation Service Product Portfolio
- 8.2.5 QuEST Recent Developments
- 8.3 Global Services
- 8.3.1 Global Services Company Information
- 8.3.2 Global Services Business Overview
- 8.3.3 Global Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Global Services Medical Device Validation Service Product Portfolio
- 8.3.5 Global Services Recent Developments
- 8.4 Intertek
- 8.4.1 Intertek Company Information
- 8.4.2 Intertek Business Overview
- 8.4.3 Intertek Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Intertek Medical Device Validation Service Product Portfolio
- 8.4.5 Intertek Recent Developments
- 8.5 Element Materials Technology
- 8.5.1 Element Materials Technology Company Information
- 8.5.2 Element Materials Technology Business Overview
- 8.5.3 Element Materials Technology Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Element Materials Technology Medical Device Validation Service Product Portfolio
- 8.5.5 Element Materials Technology Recent Developments
- 8.6 TÜV SÜD
- 8.6.1 TÜV SÜD Company Information
- 8.6.2 TÜV SÜD Business Overview
- 8.6.3 TÜV SÜD Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.6.4 TÜV SÜD Medical Device Validation Service Product Portfolio
- 8.6.5 TÜV SÜD Recent Developments
- 8.7 NAMSA
- 8.7.1 NAMSA Company Information
- 8.7.2 NAMSA Business Overview
- 8.7.3 NAMSA Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.7.4 NAMSA Medical Device Validation Service Product Portfolio
- 8.7.5 NAMSA Recent Developments
- 8.8 Eurofins Scientific
- 8.8.1 Eurofins Scientific Company Information
- 8.8.2 Eurofins Scientific Business Overview
- 8.8.3 Eurofins Scientific Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Eurofins Scientific Medical Device Validation Service Product Portfolio
- 8.8.5 Eurofins Scientific Recent Developments
- 8.9 Charles River
- 8.9.1 Charles River Company Information
- 8.9.2 Charles River Business Overview
- 8.9.3 Charles River Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Charles River Medical Device Validation Service Product Portfolio
- 8.9.5 Charles River Recent Developments
- 8.10 Sterling Medical Devices
- 8.10.1 Sterling Medical Devices Company Information
- 8.10.2 Sterling Medical Devices Business Overview
- 8.10.3 Sterling Medical Devices Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Sterling Medical Devices Medical Device Validation Service Product Portfolio
- 8.10.5 Sterling Medical Devices Recent Developments
- 8.11 Pacific Biolabs
- 8.11.1 Pacific Biolabs Company Information
- 8.11.2 Pacific Biolabs Business Overview
- 8.11.3 Pacific Biolabs Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Pacific Biolabs Medical Device Validation Service Product Portfolio
- 8.11.5 Pacific Biolabs Recent Developments
- 8.12 Toxikon
- 8.12.1 Toxikon Company Information
- 8.12.2 Toxikon Business Overview
- 8.12.3 Toxikon Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Toxikon Medical Device Validation Service Product Portfolio
- 8.12.5 Toxikon Recent Developments
- 8.13 Steris Laboratories
- 8.13.1 Steris Laboratories Company Information
- 8.13.2 Steris Laboratories Business Overview
- 8.13.3 Steris Laboratories Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Steris Laboratories Medical Device Validation Service Product Portfolio
- 8.13.5 Steris Laboratories Recent Developments
- 8.14 Europlaz
- 8.14.1 Europlaz Company Information
- 8.14.2 Europlaz Business Overview
- 8.14.3 Europlaz Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Europlaz Medical Device Validation Service Product Portfolio
- 8.14.5 Europlaz Recent Developments
- 8.15 HIGHPOWER Validation Testing & Lab Services
- 8.15.1 HIGHPOWER Validation Testing & Lab Services Company Information
- 8.15.2 HIGHPOWER Validation Testing & Lab Services Business Overview
- 8.15.3 HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.15.4 HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Product Portfolio
- 8.15.5 HIGHPOWER Validation Testing & Lab Services Recent Developments
- 8.16 Tata Elxsi
- 8.16.1 Tata Elxsi Company Information
- 8.16.2 Tata Elxsi Business Overview
- 8.16.3 Tata Elxsi Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Tata Elxsi Medical Device Validation Service Product Portfolio
- 8.16.5 Tata Elxsi Recent Developments
- 8.17 Onyx Healthcare
- 8.17.1 Onyx Healthcare Company Information
- 8.17.2 Onyx Healthcare Business Overview
- 8.17.3 Onyx Healthcare Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Onyx Healthcare Medical Device Validation Service Product Portfolio
- 8.17.5 Onyx Healthcare Recent Developments
- 8.18 QAEC
- 8.18.1 QAEC Company Information
- 8.18.2 QAEC Business Overview
- 8.18.3 QAEC Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.18.4 QAEC Medical Device Validation Service Product Portfolio
- 8.18.5 QAEC Recent Developments
- 8.19 Zener Engineering Services
- 8.19.1 Zener Engineering Services Company Information
- 8.19.2 Zener Engineering Services Business Overview
- 8.19.3 Zener Engineering Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.19.4 Zener Engineering Services Medical Device Validation Service Product Portfolio
- 8.19.5 Zener Engineering Services Recent Developments
- 8.20 Lucideon
- 8.20.1 Lucideon Company Information
- 8.20.2 Lucideon Business Overview
- 8.20.3 Lucideon Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Lucideon Medical Device Validation Service Product Portfolio
- 8.20.5 Lucideon Recent Developments
- 8.21 Applus+ Laboratories
- 8.21.1 Applus+ Laboratories Company Information
- 8.21.2 Applus+ Laboratories Business Overview
- 8.21.3 Applus+ Laboratories Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.21.4 Applus+ Laboratories Medical Device Validation Service Product Portfolio
- 8.21.5 Applus+ Laboratories Recent Developments
- 8.22 Patient Guard
- 8.22.1 Patient Guard Company Information
- 8.22.2 Patient Guard Business Overview
- 8.22.3 Patient Guard Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.22.4 Patient Guard Medical Device Validation Service Product Portfolio
- 8.22.5 Patient Guard Recent Developments
- 8.23 Medical Engineering Technologies
- 8.23.1 Medical Engineering Technologies Company Information
- 8.23.2 Medical Engineering Technologies Business Overview
- 8.23.3 Medical Engineering Technologies Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.23.4 Medical Engineering Technologies Medical Device Validation Service Product Portfolio
- 8.23.5 Medical Engineering Technologies Recent Developments
- 8.24 Tentamus
- 8.24.1 Tentamus Company Information
- 8.24.2 Tentamus Business Overview
- 8.24.3 Tentamus Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.24.4 Tentamus Medical Device Validation Service Product Portfolio
- 8.24.5 Tentamus Recent Developments
- 8.25 Test Labs
- 8.25.1 Test Labs Company Information
- 8.25.2 Test Labs Business Overview
- 8.25.3 Test Labs Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 8.25.4 Test Labs Medical Device Validation Service Product Portfolio
- 8.25.5 Test Labs Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst